Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Eckard Weber
AddedMar 31, 2024
UpdatedMay 31, 2026
Eckard Weber

Eckard Weber

Board Member, Syndax Pharmaceuticals

Crunchbase

Eckard Weber's Career

Syndax Pharmaceuticals
Syndax Pharmaceuticals

Waltham, MA, US

Board Member· Board
Domain Associates
Domain Associates

San Diego, CA, US

Founder & CEO· C-Suite · Management
RightCare Solutions
RightCare Solutions

Horsham, PA, US

Board Member· Board
Adastra Pharmaceuticals
Adastra Pharmaceuticals

San Diego, CA, US

Board Member· Board
Ascenta Therapeutics
Ascenta Therapeutics

Malvern, PA, US

Board Member· Board
Adynxx
Adynxx

San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Eckard Weber's Career

Syndax Pharmaceuticals
Syndax Pharmaceuticals
Public$803.6M1072005Waltham, MA, US
Board Member· Board

Leadership at Syndax Pharmaceuticals

Dennis PodlesakDennis PodlesakBoard Member
Michael A. MetzgerMichael A. MetzgerBoard Member
Art PappasArt PappasBoard Member
Pierre LegaultPierre LegaultBoard Member
Jennifer JarrettJennifer JarrettBoard Member
Dr. Ronald M. Evans Ph.D.Dr. Ronald M. Evans Ph.D.Board Member
Domain Associates
Domain Associates
Investment FirmInvestment Firm$97.2M301985San Diego, CA, US
Founder & CEO· C-Suite · Management

Leadership at Domain Associates

Ashton NewhallAshton NewhallBoard Member
Steven J Semmelmayer \"Steve\"Steven J Semmelmayer \"Steve\"Board Member
Dr John J SavareseDr John J SavareseBoard Member

Similar to Domain Associates

Draper AssociatesDraper AssociatesMenlo Park, CA, USest. 1985Draper AssociatesMenlo Park, CA, US · est. 1985

Menlo Park-based Draper Associates LP is a venture capital firm investing in diverse tech sectors across the US.

Investment Firm29
Dom Capital GroupDom Capital GroupChicago, IL, USest. 2007Dom Capital GroupChicago, IL, US · est. 2007

DOM Capital Group: A private investment firm partnering with entrepreneurs, valuing service, quality, and innovation since 2007.

Investment Firm6
Dominion CapitalDominion CapitalNew York City, NY, USest. 2011Dominion CapitalNew York City, NY, US · est. 2011

Dominion Capital: Diverse investment firm fueling growth in small to mid-market companies since 2011.

Investment Firm29
Durand Venture AssociatesDurand Venture AssociatesNew York City, NY, USDurand Venture AssociatesNew York City, NY, US

Investing in life science and biotech industries in the US.

Investment Firm50
RightCare Solutions
RightCare Solutions

Horsham, PA, US

Board Member· Board
Adastra Pharmaceuticals
Adastra Pharmaceuticals
Acquired$85M02005San Diego, CA, US
Board Member· Board

Leadership at Adastra Pharmaceuticals

Evgeny ZaytsevEvgeny ZaytsevBoard Member
Kim KamdarKim KamdarBoard Member
Ralph ChristoffersenRalph ChristoffersenBoard Member
Chris ChristoffersenChris ChristoffersenBoard Member
Alain SchreiberAlain SchreiberBoard Member
Chris LeMastersChris LeMastersFounder

Similar to Adastra Pharmaceuticals

Adhera TherapeuticsAdhera TherapeuticsDurham, NC, USPharmaceuticalsest. 1983Adhera TherapeuticsDurham, NC, US · est. 1983

US-based Adhera Therapeutics develops specialty pharmaceuticals for inflammatory diseases, hypertension, and cancer.

Seed · $3.2M37
Adventris PharmaceuticalsAdventris PharmaceuticalsSan Francisco, CA, USCancer Vaccinesest. 2022Adventris PharmaceuticalsSan Francisco, CA, US · est. 2022

Adventris Pharmaceuticals, a San Francisco-based firm, specializes in developing cancer vaccines.

Pre-Seed · $500k6
Novita PharmaceuticalsNovita PharmaceuticalsNew York City, NY, USCancer Drugsest. 2010Novita PharmaceuticalsNew York City, NY, US · est. 2010

Novita Pharmaceuticals: Developing and providing cancer-treatment drugs since 2010, based in New York.

Series A · $8.5M7
Ascenta Therapeutics
Ascenta Therapeutics

Malvern, PA, US

Board Member· Board
Adynxx
Adynxx
Series B$23.5M62007San Francisco, CA, US
Board Member· Board

Leadership at Adynxx

Stan AbelStan AbelBoard Member
Julien MametJulien MametBoard Member
Heath LukatchHeath LukatchBoard Member
Rick OrrRick OrrBoard Member
Greg FlesherGreg FlesherBoard Member

Eckard Weber's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · Dunamu

People Similar to Eckard Weber

Peter OrdentlichPeter OrdentlichFounder · Syndax PharmaceuticalsBriggs W MorrisonBriggs W MorrisonBoard Member · ArvinasAhmad AbbasiAhmad AbbasiCo-Founder · SyndicaBradley CarverBradley CarverBoard Member · Syndevrx